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Because of the body’s resistance to permanent weight change, 
obesity remains a major health problem in modern society. It 
is hypothesized that the regulatory system defending body 
weight utilizes pancreatic insulin as an indicator of adiposity 
to the brain. To take advantage of this negative feedback 
system, we transplanted neonatal (experiment 1) or adult 
(experiment 2) pancreatic islets containing insulin-secreting 
cells into the 3rd ventricle of syngeneic Lewis rats. This 
resulted in an elevation of the insulin signal within the brain 
and a significant long-term reduction of body weight. Changes 
in food intake were consistent with the changes of body 
weight. The implantation of more islets resulted in a greater 
reduction of body weight, and changes in weight were in- 
versely correlated with the level of insulin achieved in the 
cerebrospinal fluid. After the two studies were completed, 
histological examination revealed the presence of insulin- 
containing cells within the 3rd ventricle and adjacent hypo- 
thalamus. These studies suggest that transplanted insulin- 
secreting cells may provide a potential therapeutic strategy for 
maintenance of weight loss. 
brain insulin; insulin; food intake; transplantation 
OBESITY AND ITS ASSOCIATED medical and social conse- 
quences present a major health problem to modern 
society (6, 26, 29). Despite numerous experimental and 
therapeutic approaches that have been applied to reduce 
the incidence and severity of obesity over the past 50 yr, 
the fact remains that most overweight individuals are 
likely to remain so throughout their adult lives (6, 11, 
26, 29). One popular explanation is that adiposity 
appears to be tightly regulated; i.e., behavioral and 
physiological controls exist that maintain body fat at 
some predetermined level or “set point.” Hence, at- 
tempts to lower weight and maintain weight loss through 
such diverse means as dieting, behavioral modification, 
use of anorexigenic drugs, lipectomy, or surgery de- 
signed to reduce the absorptive area of the gut all work 
against this robust innate control system. One conse- 
quence is that over time, individuals who lose weight by 
any of these means tend to regain it. The converse is also 
true because the regulatory system controlling body 
weight is symmetrical. When excess fat is experimen- 
tally induced, and subjects are subsequently allowed to 
feed freely, food intake is reduced until adiposity returns 
to normal levels (5,25). 
The presumption underlying all of these findings is 
that a signal proportional to body fat interacts with 
fat-controlling systems in the brain to contribute to the 
homeostatic maintenance of weight. When an individual 
is below his or her normal or defended level of adiposity, 
the adiposity-regulating areas of the brain presumably 
receive a reduced or altered adiposity feedback signal 
that serves to increase appetite and adjust metabolism 
until fat is restored (21, 30). An obvious strategy to 
lower body weight would therefore be to elevate the 
adiposity signal experimentally (or therapeutically) with- 
out changing the actual fat content of the body and 
thereby activate intrinsic adiposity-reducing mecha- 
nisms. 
Although the nature of the adiposity signal is poorly 
understood (26), there is compelling evidence from 
studies on parabiotic animals to suggest that an adipos- 
ity feedback signal circulates in the blood and that its 
administration to animals results in reduced food intake 
and weight loss (9, 13). The pancreatic hormone insulin 
is a strong candidate for the elusive adiposity-related 
signal (21, 29, 30). Insulin is secreted into the blood in 
direct proportion to the degree of adiposity (25), and a 
specific transport system exists that passes insulin from 
the blood into the brain (20, 23). Within the brain, 
specific insulin receptors are found on neurons in areas 
known to be important in the control of food intake and 
body weight (3, lo), and the synthesis of at least one 
brain neuropeptide important in feeding, neuropeptide 
Y, appears to be under the direct control of brain insulin 
levels (22,24). 
When exogenous insulin is administered directly into 
the central nervous system, it elicits decreased feeding 
and body weight. This phenomenon has been demon- 
strated in numerous species, including rats (1,7,14,17), 
baboons (31), and marmots (12). The reductions of food 
intake and body weight are dose dependent (7, 31) and 
reliant on insulin administration into appropriate cen- 
tral locations because some sites appear nonresponsive 
(17). The most robust demonstrations of the phenom- 
enon have occurred when insulin is administered into 
the 3rd ventricle (1, 7, 14) or directly into the ventral 
hypothalamus of rats (17). 
In the past, central administration of insulin has been 
accomplished via cannulation of the central nervous 
system coupled with continuous or intermittent admin- 
istration of insulin from an exogenous source. Although 
the suppression of food intake and/or body weight 
elicited by the infusion of exogenous insulin does not 
reverse immediately when the infusion is stopped (7, 
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a few days. In an attempt to establish a long-term and 
potentially therapeutically useful method for introduc- 
ing insulin into the brain and hence causing a chronic 
reduction in body adiposity, we have developed a method 
for transplanting viable insulin-secreting pancreatic cells 
into the ventricular system of rats. The results suggest 
that such cells thrive and secrete insulin locally within 
the brain and that this may provide a strategy to achieve 
permanent weight loss. 
METHODS 
General Procedures 
Surgical procedures. For third ventricular cannulation, rats 
were anesthetized with Equithesin (3.0 ml/kg ip) and placed in 
a stereotaxic apparatus (Kopf). The animal’s head was ad- 
justed in the horizontal plane so that bregrna and lambda had 
the same dorsal-ventral coordinate. A 22-gauge guide cannula 
with a 28-gauge internal obturator (Plastics One, Roanoke, 
VA) was lowered ventrally at coordinates 7.2 mm anterior to 
the interaural line and on the midline. The tip was lowered 7.0 
mm below the cortical surface directly ventral to the midsagit- 
tal sinus. To accomplish this, the midsagittal sinus was 
retracted laterally and then allowed to settle against the guide 
cannula. The cannula was anchored to the skull with dental 
acrylic and stainless steel anchor screws. 
Animals received a prophylactic injection of gentamicin 
(300,000 U/ml im; 0.2 ml/rat) immediately after surgery. All 
subjects were allowed to recover to presurgery body weight 
before receiving experimental or control treatments. To con- 
firm placement of the cannulas, rats were injected with 4 ~1 of 
10 kg/ml angiotensin II (ANG II). To be eligible for inclusion 
in the transplantation studies, a rat had to consume at least 5 
ml of water within 30 min after the injection intracranially of 
the ANG II. 
Isletpreparation. Pancreatic islets were isolated from neona- 
tal (experiment 1) or adult (experiment 2) Lewis rats after 
collagenase digestion of the pancreas and separation of the 
islets from the exocrine cells by Percoll gradient centrifugation 
as previously described (8). The islets were suspended in 
RPMI-1640 culture medium (GIBCO, Grand Island, NY) 
supplemented with 10% (wt/vol) heat-inactivated fetal calf 
serum (GIBCO), 20 mM N-2-hydroxyethylpiperazine-N’-2- 
ethanesulfonic acid, 2 mM/L-glutamine, 24 mM Na-HCOs, 100 
U/ml penicillin, and 100 kg/ml streptomycin (RPM1 medium) 
and individually selected under a stereomicroscope. The yield 
was - 100 islets/pancreas. After culture overnight in RPM1 
medium at 37°C in a humidified atmosphere of 5% COZ-95% 
air, healthy-appearing islets were carefully reselected for 
implantation under the stereomicroscope before being im- 
planted. 
Met implantation. Individual pancreatic islets were counted 
through the tip of an injection cannula into polyethylene 
tubing (PE-20, Clay Adams) filled with synthetic cerebrospinal 
fluid (CSF) and attached to a microsyringe (Hamilton). Rats 
were anesthetized with halothane and received islets or con- 
trol solution into the 3rd ventricle. The total volume necessary 
to collect and infuse the islets never exceeded 12 ~1 in any 
given condition and was administered over an interval of - 6 
min. Penicillin G (Bicillin, 300,000 U/ml) was administered 
(0:2 ml/rat im) immediately after each procedure. 
Dependent measures. Body weight was measured each day 
for the duration of the experiment. Because food intake was 
depressed for several days after the combined surgical and 
implantation procedures, we do not report values until they 
had stabilized (3-4 days). At the end of the experiment, 
continuing animals were anesthetized with ketamine (100 
mg/kg ip) and cisternal CSF samples were taken as previously 
described (27). Blood samples were taken by cardiac puncture. 
The rat was then perfused intracardially with saline, and the 
brain was removed and fixed in Bouin-Hollande solution for 
subsequent immunocytochemical analysis. Blood was centri- 
fuged and plasma was frozen at -20°C until assayed for 
immunoreactive insulin (IRI) by a modification of the double- 
antibody method (18) and for glucose by the glucose oxidase 
method. Cell-free CSF samples were frozen, and IRI was 
assayed by the highly sensitive method of Baskin et al. (4). 
Histology. Brains were embedded in paraffin, and serial 5 
pm-thick coronal sections were mounted on slides. After 
removal of paraffin and hydration, slides were placed in 
distilled water for 30 min at room temperature (RT). Sections 
were covered with 0.5-ml drops of immunostaining reagents, 
starting with 1% normal sheep serum in tris(hydroxymethyl)- 
aminomethane (Tris) buffer (0.5 m) containing 0.9% NaCl for 
30 min at RT. After a rinse in Tris buffer saline (TBS), they 
were covered with undiluted mouse monoclonal antibody to 
insulin (AM029-5M, Biogenex Laboratories, San Ramon, CA) 
for 48 h at 6°C in a covered humid chamber. They were then 
rinsed in TBS and covered with biotinylated anti-mouse 
immunoglobulin (1g)G (Biogenex) for 20 min (RT), followed by 
a TBS rinse and alkaline phosphatase-streptavidin conjugate 
(20 min; RT) from a Biogenex StrAviGen detection kit. 
Alkaline phosphatase was detected with a fast red chromogen 
system (Biogenex) for 5 min at RT, and the sections were cover 
slipped with glycerol. Control sections were treated with 
nonimmune mouse IgG. As a positive control, we demon- 
strated that this procedure intensely stained P-cells in the 
islets of rat pancreas sections that were measured in parallel 
with the brain sections. 
Statistics. All data were analyzed with t tests or repeated 
measures analysis of variance. 
Experiment 1 
Adult male syngeneic Lewis rats (Simonsen) weighing - 300 
g served as subjects. Animals were individually housed in 
standard stainless steel hanging cages in a light- and tempera- 
ture-controlled room. Food (Wayne pellets) and water were 
available ad lib. 
Islets were provided by neonatal Lewis rats. There were two 
implantations of islets (or control solution), the first (50 islets) 
occurring 1 wk after cannula implantation and the second (100 
additional neonatal islets) occurring 27 days later. The ani- 
mals were monitored for an additional 30 days after the second 
implantation. 
Control animals received one of three treatments: an equi- 
volumetric third ventricular injection of the islet culture 
medium diluted with synthetic CSF (the vehicle); bilateral 
ventromedial hypothalamic injections (27-gauge guide can- 
nula with a 30-gauge internal cannula at coordinates: antero- 
posterior (AP) 5.8, dorsoventral (DV) -3.5, and 1.0 mm lateral 
from midline) of the vehicle mixture. This site is reported to be 
particularly sensitive to local insulin administration (17). The 
final site received a bilateral injection of 50 pancreatic islets 
into the lateral hypothalamic area at coordinates AP 5.0, 
DV -3.0, and 2.0 mm lateral from midline. This area is 
reported not to be responsive to local application of insulin 
(17). Only the first of these three control groups was continued 
to the end of the experiment. The others were terminated at 
the time of the second implantation. 
Experiment 2 
Male Lewis rats (Simonsen) weighing 250-300 g served as 
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diet before islet or control implantation. After implantation 
they were given ad lib water plus the liquid diet, Ensure (Ross 
Laboratories, Columbus, OH) to determine if the phenomenon 
might be enhanced with a more palatable diet. 
For this experiment, the identical procedure used in experi- 
ment 1 was followed except that the islets were obtained from 
adult rather than neonatal donors. Experimental animals 
received one implantation of 150 islets into the 3rd ventricle. 
Control animals received an isovolumetric injection of the 
incubation medium for the islets into the 3rd ventricle (as in 
the previous study) or an isovolumetric injection of a suspen- 
sion of small pieces of exocrine tissue into the 3rd ventricle. 
The pieces of exocrine tissue were harvested from the same 
pancreas as the endocrine islets. Their size was comparable 
with that of average islets, and they were treated identically as 
the endocrine islets. 
RESULTS 
Experiment 1 
Animals in the three control conditions (n = 11) did 
not differ significantly on any dependent measure and 
were combined for subsequent analyses. Rats receiving 
islets into the 3rd ventricle (n = 5) had a significant and 
persistent reduction of body weight relative to controls 
that became apparent within 2 days of receiving islets [F 
(1, 14) 12.70, P < 0.01, Fig. 11. Food intake was also 
reduced but was more variable and did not attain 
statistical significance. 
The effect of receiving the additional 100 islets is 
depicted in Fig. 2. It is important to note that only one 
control condition (n = 4) is included in this part of the 
experiment and that the absolute weights of the two 
groups differed on the day of the second transplantation: 
day 0 (controls 432.4 - + 20.2 gvs. islet group 407.5 t 4.8 
g; NS). Experimental animals receiving islets (n = 5) 
experienced an additional reduction of weight relative to 
controls, and the controls continued to weigh more than 
the transplanted animals for the duration of the study 
(F (1,9) 5.11, P < 0.05, one tailed). 
Glucose and IRI. The number of rats with sufficient 
CSF and plasma samples for assay at the end of 57 days 
was low (exptl n, 5; control n, 3). Hence, comparisons 
-5 0 5 10 15 
DAYS 
Fig. 1. Mean + SE change of body weight for control rats (0, zz = 11) 
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DAYS 
Fig. 2. Mean + SE change of body weight for control rats (0) and rats 
receiving additional 100 transplanted islets 37 days after initial 
transplant (0). Absolute weights of 2 groups differed on day of 
transplantation (day 0). Only 1 subset of control rats depicted in Fig. 1 
was continued for this part of experiment. 
between two groups were difficult. Median plasma glu- 
cose was comparable for the experimental and control 
animals when killed (control rats median, 123 mg/dl; 
experimental rats median, 121 mg/dl). Median plasma 
IRI levels were also not different (control rats median, 
10 kU/ml; experimental rats median, 10 pU/ml). De- 
spite the few number, experimental rats had elevated 
CSF IRI (0.73 t 0.09 vs. 0.47 t 0.03 (SE) @J/ml; 
t= 2.16, P < 0.05, by one-tailed t test) relative to 
controls. Importantly, the change of weight over the 
course of the experiment was inversely correlated with 
CSF IRI for these rats when killed (r = -0.75, df = 6, 
P < 0.05). 
Histology. Histological examination of the brains by 
light microscopy revealed viable transplanted cells within 
close proximity to the 3rd ventricle of experimental 
animals. Immunocytochemical analysis indicated that 
these cells contained IRI-like substance. The goal in this 
analysis was to identify the presence of insulin- 
containing cells within the the hypothalamus. Although 
a detailed mapping of the location was not made, some 
generalizations can be made. Insulin-positive cells were 
attached to the ependymal lining of the floor and walls of 
the 3rd ventricle of experimental rats. In some experi- 
mental rats, other insulin-positive cells appeared to 
have invaginated into the neuropil in the arcuate- 
median eminence area (Fig. 3). No insulin-positive cells 
were observed in vehicle-injected control animals. 
Experiment 2 
There was no reliable difference between the two 
control groups (n = 7) on any measure. Therefore the 
two groups were combined for the analyses. As seen in 
Fig. 4, the effect of receiving 150 adult islets into the 3rd 
ventricle on body weight (n = 8) was comparable with 
what was observed in experiment 1. Animals receiving 
150 adult islets of Langerhans significantly reduced 
their body weights relative to controls [F (1, 13) 6.95, 
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Fig. 3. Section through floor of 3rd ventricle of rat 
that received a total of 150 transplanted islets 
(magnification x 400). Section was immunostained 
to reveal insulin-containing cells (darker appear- 
ing). Insulin-cont,aining cells are located within 
arcuate nucleus. 
such that the values for experimental animals paralleled 
those for the controls for the duration of the experi- 
ment. 
As in experiment 1, food intake was quite variable. 
The experimental and control rats were not different 
before the transplantation procedure (islet group, 
30.9 t 5.5 gdiet; controls, 26.9 * 2.1 gdiet, NS). On the 
5th day post-transplantation, which was the 1st day that 
food intake was recorded, animals receiving islets con- 
sumed 69.7 i 6.5 ml Ensure and controls consumed 
84.4 I 3.1 ml [t (11) 2.04, P < 0.05). Thereafter, the 
differences lessened and did not attain significance on 
any other individual day. 
At the termination of the experiment rats with trans- 
planted islets had slightly higher CSF IRI than controls 
(2.12 ? 0.22 and 1.67 i 0.33 kU/ml, respectively, NS). 
All brains appeared healthy at autopsy, and as was the 
case in experiment 1, light microscopy revealed the 
presence of transplanted cells within the 3rd ventricle of 
experimental but not control animals. Because of the 
accidental thawing of a freezer, subsequent immunohis- 
tochemical analysis could not be performed on these 
samples. 
DISCUSSION 
Although the total number of subjects in each experi- 
ment is small, the results of the two experiments are 
consistent. Animals that received transplanted islets 
into the 3rd ventricle had a persistent and significant 
reduction of body weight. They maintained a weight 
that was reduced yet parallel to that of controls over 
time. Food intake data were consistent but far more 
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Fig. 4. Mean + SE change of body weight for control rats (0, n = 7) 
and rats receiving 150 3rd 
15 days of experiment 2. 
ventricular adult islets (0, n = 8) over first 
had reduced intake relative to controls, but the differ- 
ences reached significance only in experiment 2 and for 
only a brief interval after the transplantation procedure. 
In preliminary studies not reported here but address- 
ing the same question (19), Long-Evans rats served as 
subjects. In those studies experimental animals received 
third ventricular injections of up to 150 islets isolated 
from neonatal Wistar rats. Although the food intake and 
body weight of animals receiving islets became signifi- 
cantly reduced relative to controls, the effect peaked 
within the 1st wk and began to diminish by the 2nd wk 
of the study. Histological examination after 2 wk failed 
to reveal viable insulin-containing granules in the brains 
of experimental animals, and the presumption was that 
the transplanted cells had been rejected by the host. We 
therefore utilized syngeneic Lewis rats for the present 
studies. 
Successful central nervous system (CNS) transplanta- 
tion of pancreatic islets has been previously reported 
(16, 28). In th ose studies, large numbers of islets 
( - 2,500) were transplanted into the lateral ventricles of 
streptozotocin-diabetic rats in an attempt to reduce the 
degree of glucose intolerance. The transplanted cells 
were functional and viable for > 175 days. Similar to 
what we observed in experiment 1, histological examina- 
tion of the transplant site revealed cells that were well 
vascularized, that had invaginated into the neuropil, 
and that stained positive for insulin. It is noteworthy 
that reductions of body weight were not observed in 
those experiments. However, in those experiments the 
islets had been implanted into the lateral ventricles, and 
it has been reported that in rats, third (1, 7, 14) but not 
lateral (15) ventricular infusions of insulin reduce food 
intake and body weight. Furthermore, all treated rats 
had severe diabetes mellitus and were underweight 
relative to controls before the transplantations. The 
present results are therefore consistent with the earlier 
findings that islets transplanted into the CNS survive 
for long intervals and that third ventricular administra- 
tion of insulin into otherwise normal animals is effective 
at reducing body weight. Considering the stable and 
long duration of weight loss obtained with the syngeneic 
rats, there is every indication that the transplanted 
islets might survive indefinitely and that the weight loss 
might be maintained. 
It is noteworthy that rats receiving islets had elevated 
CSF IRI, although with the few number of subjects the 
difference was only significant in experiment 1. Al- 
though the absolute magnitude of the difference was 
small, it was apparently effective because CSF insulin 
levels when the rats were killed were inversely corre- 
lated with weight gain in experiment 1. Furthermore, 
there is now compelling evidence that CSF insulin 
values are lower than what is actually seen by neurons 
in the CNS (20,21,23). This is important because many 
insulin-secreting cells in the present experiment were 
actually found to reside within the neuropil of the 
ventral hypothalamus. Interstitial fluid insulin levels 
might have been quite high in some regions of the 
ventral hypothalamus, and this area is known to be 
responsive to the suppressive effects of insulin on food 
intake (17). The absolute level of CSF IRI in all rats was 
higher in experiment 2 than in experiment 1. This is 
presumably because of the diet (Ensure) of the rats in 
the second experiment relative to the first. 
Although the decrease of body weight observed in the 
present experiment was modest, it was highly reliable 
and sensitive to critical manipulations. In experiment 1, 
the decrease in weight was enhanced when additional 
islets were implanted. In experiment 2, comparable 
results were obtained with a different diet and with use 
of adult instead of neonatal islets. Every indication is 
that the islets were viable and releasing insulin and that 
this is what caused the observed results. 
It is not clear what constitutes an appropriate control 
condition for studies of this type. In the present experi- 
ments, we administered the incubation medium as well 
as islet-sized pieces of exocrine pancreas into the 3rd 
ventricle. We also administered islets into an area of the 
brain demonstrated to be insensitive to exogenous insu- 
lin. None of these conditions altered the feeding or 
growth curves of the rats, and implantation of viable 
islets into the 3rd ventricle resulted in reduced body 
weight relative to all of these. 
These studies confirm and are in agreement with past 
experiments that have demonstrated the ability of exog- 
enous insulin to lower an animal’s body weight (1, 7, 12, 
14, 17, 31). In past studies, intraventricular insulin has 
been administered via infusion pumps (31), osmotic 
pumps (1,7,14), or by repeated acute injections (22,24). 
Because all of the above-mentioned systems of elevating 
CNS insulin levels are temporally limited, the termina- 
tion of each administration regimen typically returns 
animals to preinfusion body weight within a short 
period of time. In summary, these studies provide 
evidence that central transplants of pancreatic islets 
might provide a means of chronically exposing the brain 
to elevated insulin levels and thus cause a decrease in 
body weight that is maintained. 
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